Ritanserin
CAY-21374-10 10 mg
Data Sheet: 
SDS:
SDS:
CAS
87051-43-2
Formulation
A crystalline solid
Purity
≥95%
MW
477,6
Shipment
-20
Long Term Storage
-20
Shelf Life
730
Description
Ritanserin is a selective antagonist of the serotonin (5-HT) receptor subtype, 5-HT2A.{39295} In a radioligand binding assay, ritanserin exhibits high selectivity for 5-HT2A over 5-HT1 receptors (IC50s = 0.9 nM and >1000 nM, respectively).{39296} It also demonstrates relatively low affinity for histamine H1, dopamine D2, α1-adrenergic, and α2-adrenergic receptors (39-, 77-, 107-, and 166-fold lower relative to 5-HT2A, respectively). Ritanserin (2.5 mg/kg) is long-acting, occupying >70% of 5-HT2A sites up to 48 hours following subcutaneous administration to rats and guinea pigs. In vivo, ritanserin (10 mg/kg) blocks 5-hydroxy tryptophan-induced head twitches in rats.{39297}
ESCLUSIVAMENTE PER USO DI RICERCA (RUO) e non per uso terapeutico o diagnostico su uomini o animali. Il prodotto NON è un Dispositivo Medico o un Diagnostico in Vitro.
PRODUCT FOR RESEARCH USE ONLY (RUO) and not for therapeutic or diagnostic use on humans or animals. The product is NOT a Medical Device or an In-Vitro Diagnostic (IVD).
